유아 영양 시장 규모, 점유율 및 추세 분석 보고서의 글로벌 올리고당 – 2031년까지의 산업 개요 및 예측

유아 영양 시장 분석의 올리고당

영유아 영양 시장의 올리고당은 이러한 생물학적 활성 화합물과 관련된 건강상의 이점에 대한 인식이 증가함에 따라 상당한 성장을 경험하고 있습니다. 주로 모유에서 발견되는 올리고당은 영유아의 장 건강, 면역 및 전반적인 발달에 필수적입니다. 모유 수유율이 전 세계적으로 다양하고 고품질 영유아용 조제분유에 대한 필요성이 증가함에 따라 제조업체는 올리고당을 통합하여 모유의 영양 프로필을 밀접하게 모방하고 있습니다. 올리고당 생산의 기술적 발전과 지원 규제 프레임워크는 시장 성장을 더욱 촉진합니다.

유아 영양 시장 규모에서의 올리고당

영유아 영양 시장의 글로벌 올리고당 규모는 2023년에 2억 1,619만 달러로 평가되었으며, 2031년까지 3억 6,594만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 9.0%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 지리적으로 표현된 회사별 생산 및 용량, 유통업체 및 파트너의 네트워크 레이아웃, 자세하고 업데이트된 가격 추세 분석, 공급망 및 수요의 적자 분석이 포함됩니다.

보고 범위 및 시장 세분화       

유아 영양 시장 정의의 올리고당

Oligosaccharides in infant nutrition refer to complex carbohydrates composed of short chains of sugar molecules, which are naturally found in human breast milk and are essential for the growth and development of infants. These bioactive compounds play a crucial role in promoting gut health by acting as prebiotics, stimulating the growth of beneficial gut bacteria. Oligosaccharides support the development of the immune system and may help protect against infections by preventing the adhesion of harmful pathogens to the gut lining.

Oligosaccharides in Infant Nutrition Market Dynamics

Drivers

• Growing Awareness of Infant Health    

Parents today are more informed about the critical role of early nutrition in their children's development. They seek products that can offer the closest possible match to the benefits of natural breastfeeding. Oligosaccharides, known for their role in promoting gut health and boosting the immune system, are becoming a key ingredient in premium infant formulas. This growing awareness is pushing manufacturers to incorporate these beneficial compounds, thus expanding the market for oligosaccharides in infant nutrition. Increasing awareness among parents about the importance of infant health and nutrition is driving the demand for oligosaccharides in infant formulas.       

• Rising Demand for Breastfeeding Alternatives           

As breastfeeding rates fluctuate globally, there is a higher demand for infant formulas that closely replicate the benefits of human breast milk, including the addition of oligosaccharides. Many mothers are unable to breastfeed due to medical, personal, or professional reasons, leading them to seek alternatives that can provide similar nutritional benefits. Infant formulas enriched with oligosaccharides offer a solution by mimicking the prebiotic effects found in human milk, promoting better digestive health and immune function in infants. This increasing reliance on high-quality formula products is significantly driving the oligosaccharides market.

Opportunities

• Technological Advancements in Incorporation of Oligosaccharides  

Innovations in the production and incorporation of oligosaccharides into infant nutrition products are enhancing their availability and effectiveness. Advances in biotechnology and food science have enabled the efficient extraction and synthesis of oligosaccharides, making them more accessible for use in infant formulas. These technological breakthroughs are not only improving the quality and efficacy of the products but also reducing production costs over time. This progress opens up new opportunities for manufacturers to develop and market a broader range of oligosaccharide-enriched infant nutrition products, creating new opportunities for growing consumer demand for advanced nutritional solutions.   

• Increasing Disposable Incomes      

Higher disposable incomes, particularly in emerging economies, are enabling consumers to spend more on premium infant nutrition products. As economies grow and living standards rise, parents in these regions are more willing and able to invest in high-quality nutrition for their infants. This trend is driving the demand for specialized and enriched formulas, including those containing oligosaccharides. The increasing purchasing power allows more consumers to opt for products that offer superior health benefits, thereby creating new opportunities for the market for oligosaccharides in infant nutrition.

Restraints/Challenges

• High Production Costs

The complex process of producing oligosaccharides can be expensive, potentially limiting their affordability and widespread use in infant nutrition. The production of oligosaccharides involves advanced biotechnological processes and stringent quality control measures, which contribute to high manufacturing costs. These expenses are often passed on to consumers, making oligosaccharide-enriched formulas more costly than standard options. This cost barrier can limit market growth, especially in price-sensitive regions where consumers may opt for more affordable alternatives.

• Limited Awareness in Developing Regions

In some developing regions, there is still limited awareness about the benefits of oligosaccharides in infant nutrition, which can slow market penetration. Despite the known health advantages, many parents and healthcare providers in these areas are not fully informed about the role of oligosaccharides in promoting gut health and boosting immunity. This lack of knowledge can hinder the adoption of oligosaccharides in nutrition.

Top of Form

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Latest Developments in Oligosaccharides in Infant Nutrition Market

• In November 2023, Nestlé announced the launch of its science-based growing-up milk solution featuring Human Milk Oligosaccharides (HMOs) for early life nutrition in mainland China, under the Wyeth illuma brand. This launch follows the recent approval by the National Health Commission of China for the use of these bioactive ingredients
• In November 2020, Abbott introduced its most innovative infant formula to date, Similac Pro-Advancewith 2'-Fucosyllactose Oligosaccharide (2'-FL), marking the first product in Canada to feature this ground breaking ingredient in infant formula

Oligosaccharides in Infant Nutrition Market Scope

The market is segmented on the basis of type and application. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Galactoligosaccharides
• Human Milk Oligosaccharides
• Fructooligosaccharides

Application

• Food
• Health Products
• Drinks
• Medicine
• Others

Oligosaccharides in Infant Nutrition Market Regional Analysis

The market is analyzed and market size insights and trends are provided by country, type, and application as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to the rising disposable income of the population in countries such as China, India, and Japan. As economic conditions improve, more parents in these regions can afford premium infant nutrition products, including those enriched with oligosaccharides.       

아시아 태평양 지역은 식품 및 제과류 생산에 사용되는 간헐적 칼로리 감미료를 포함한 혁신적이고 고품질의 영양 제품에 대한 수요가 증가함에 따라 상당한 성장을 보일 것으로 예상됩니다. 이 지역의 잘 확립된 의료 인프라, 높은 소비자 인지도, 선도적인 영유아 영양 회사의 강력한 시장 입지가 이러한 추세에 기여합니다.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 하류 및 상류 가치 사슬 분석, 기술 추세, 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 지역 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세의 영향 및 무역 경로가 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

영유아 영양 시장 점유율의 올리고당

시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 지역적 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 회사의 시장 집중과만 관련이 있습니다.

시장에서 활동하는 주요 시장 주체는 다음과 같습니다.

• 애벗(미국)
• DuPont 영양 및 건강(미국)
• 프리슬란트캄피나 도모(네덜란드)
• 인그리디언(미국)
• 카보신스(영국)
• 데어리 크레스트(영국)
• 인비오스(벨기에)
• Jennewein Biotechnologie (독일)
• 테레오스(프랑스)
• 주켐(미국)
• 엘리시틸(프랑스)
• 덱스트라(영국)

SKU-23105